Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-011279
Filing Date
2021-05-13
Accepted
2021-05-13 16:06:01
Documents
53
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 318092
2 ex31-1.htm EX-31.1 17097
3 ex31-2.htm EX-31.2 17092
4 ex32-1.htm EX-32.1 6785
5 ex32-2.htm EX-32.2 7066
  Complete submission text file 0001493152-21-011279.txt   2477071

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE codx-20210331.xml EX-101.INS 298050
7 XBRL SCHEMA FILE codx-20210331.xsd EX-101.SCH 32973
8 XBRL CALCULATION FILE codx-20210331_cal.xml EX-101.CAL 47050
9 XBRL DEFINITION FILE codx-20210331_def.xml EX-101.DEF 90329
10 XBRL LABEL FILE codx-20210331_lab.xml EX-101.LAB 282496
11 XBRL PRESENTATION FILE codx-20210331_pre.xml EX-101.PRE 202165
Mailing Address 4049 SOUTH HIGHLAND DRIVE SALT LAKE CITY UT 84124
Business Address 4049 SOUTH HIGHLAND DRIVE SALT LAKE CITY UT 84124 8012789769
Co-Diagnostics, Inc. (Filer) CIK: 0001692415 (see all company filings)

EIN.: 462609396 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38148 | Film No.: 21919584
SIC: 3841 Surgical & Medical Instruments & Apparatus